e-learning
resources
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation
Aldo Iacono, Marniker Wijesinha, Keshava Rajagopal, Natalia Murdock, Irina Timofte, Bartley Griffith, Michael Terrin
Source:
ERJ Open Res, 5 (4) 00167-2019; 10.1183/23120541.00167-2019
Journal Issue:
October
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Aldo Iacono, Marniker Wijesinha, Keshava Rajagopal, Natalia Murdock, Irina Timofte, Bartley Griffith, Michael Terrin. A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation. ERJ Open Res, 5 (4) 00167-2019; 10.1183/23120541.00167-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
BAL neutrophil levels in a randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome post lung transplantation
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012
A retrospective analysis of our lung transplant cohort for the dichotomy within bronchiolitis obliterans syndrome and azithromycin therapy
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011
The efficacy of inhaled tiotropium add-on to budesonide/formoterol in patients with bronchiolitis obliterans after hematopoietic stem cell transplantations
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans
Source: Eur Respir J 2004; 23: 384-390
Year: 2004
Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
A prospective, open-label pilot-study of azithromycin for lung allograft lymphocytic bronchiolitis: Preliminary results
Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights
Year: 2010
Treatment options in patients with bronchiolitis obliterans syndrome
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005
Clinical and biological effects of chronic low dose azythromycin treatment in patients with bronchiolitis obliterans
Source: Eur Respir J 2007; 30: Suppl. 51, 517s
Year: 2007
Multiple breath washout in bronchiolitis obliterans syndrome following paediatric lung transplantation
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012
Post hoc analysis of a randomized trial of azithromycin in bronchiolitis obliterans syndrome after Lung transplantation (BOS); Lung function and survival
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Source: Eur Respir J 2008; 32: 832-842
Year: 2008
A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Source: Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018
Year: 2018
Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure?
Source: Eur Respir J 2011; 37: 10-12
Year: 2011
Double-blind placebo controlled randomized trial of montelukast in acute RSV bronchiolitis
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007
A randomized trial of the effectiveness of nebulized therapy with epinephrine compared with salbutamol in the treatment of acute viral bronchiolitis
Source: Eur Respir J 2005; 26: Suppl. 49, 127s
Year: 2005
Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study
Source: Eur Respir J 2005; 25: 490-493
Year: 2005
Inhaled racemic adrenalin versus saline in acute bronchiolitis, a multicenter randomized double-blind clinical trial
Source: Annual Congress 2012 - New insights into respiratory infections in children
Year: 2012
Randomized controlled trial of nebulized budesonide suspension in acute severe exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 244s
Year: 2002
Efficacy of fenspiride in infants with bronchiolitis: a preliminary open label clinical trial
Source: Eur Respir J 2004; 24: Suppl. 48, 24s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept